Geron Corp. buy klostergang
Start price
26.06.15
/
50%
€3.58
Target price
07.12.15
€4.50
Performance (%)
29.46%
End price
07.12.15
€4.63
Summary
This prediction ended on 07.12.15 with a price of €4.63. The prediction had a final performance of 29.46%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Geron Corp. | 2.047% | 2.047% | 12.928% | -54.575% |
| iShares Core DAX® | -0,46 % | -0,83 % | 0,52 % | 50,56 % |
| iShares Nasdaq 100 | -1,41 % | -3,02 % | 27,53 % | 82,27 % |
| iShares Nikkei 225® | -1,25 % | -7,63 % | 45,08 % | 68,20 % |
| iShares S&P 500 | -1,15 % | 0,59 % | 21,66 % | 64,99 % |
Comments by klostergang for this prediction
In the thread Geron Corp. diskutieren
Mit JNJ-Partnerschaft und Orphan Drug der FDA gegen Krebs :
Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.